N-{4-[2-(2-Amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)-ethyl]benzoyl}-L-glutamic Acid

ID: ALA522455

PubChem CID: 42637226

Max Phase: Preclinical

Molecular Formula: C20H20N4O6S

Molecular Weight: 444.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc2sc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cc2c(=O)[nH]1

Standard InChI:  InChI=1S/C20H20N4O6S/c21-20-23-17(28)13-9-12(31-18(13)24-20)6-3-10-1-4-11(5-2-10)16(27)22-14(19(29)30)7-8-15(25)26/h1-2,4-5,9,14H,3,6-8H2,(H,22,27)(H,25,26)(H,29,30)(H3,21,23,24,28)/t14-/m0/s1

Standard InChI Key:  SPLMCWYQFZQLIA-AWEZNQCLSA-N

Molfile:  

     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
   -2.8201    1.9947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8235    1.1697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1127    0.7563    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1058    2.4063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3992    1.9888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4027    1.1628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6180    0.9055    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1278    1.5683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6123    2.2393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5397    0.7571    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1024    3.2312    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6970    1.5648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1146    2.2781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9396    2.2746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3443    1.5584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1685    1.5545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5868    2.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1709    2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    2.9877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4118    2.2660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8201    1.5498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8243    2.9797    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6451    1.5474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0576    0.8313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0617    2.2612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8867    2.2588    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6492    2.9774    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8826    0.8289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2910    0.1168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1159    0.1144    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8785   -0.5970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 14 15  2  0
  3  6  1  0
 15 16  1  0
  6  7  1  0
 16 17  2  0
  7  8  1  0
 17 18  1  0
  8  9  2  0
 18 19  2  0
 19 14  1  0
  9  5  1  0
 17 20  1  0
  5  4  1  0
 20 21  1  0
  2 10  1  0
 20 22  2  0
  5  6  2  0
 21 23  1  0
  4 11  2  0
 23 24  1  0
 23 25  1  6
  8 12  1  0
 25 26  1  0
  1  2  1  0
 25 27  2  0
 12 13  1  0
 24 28  1  0
  1  4  1  0
 28 29  1  0
 13 14  1  0
 29 30  2  0
  2  3  2  0
 29 31  1  0
M  END

Associated Targets(Human)

KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GART Tclin GAR transformylase (531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FOLR1 Tclin Folate receptor alpha (184 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FOLR2 Tchem Folate receptor beta (148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gart GAR transformylase (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 444.47Molecular Weight (Monoisotopic): 444.1104AlogP: 1.40#Rotatable Bonds: 9
Polar Surface Area: 175.47Molecular Species: ACIDHBA: 7HBD: 5
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.34CX Basic pKa: 2.31CX LogP: 1.63CX LogD: -4.65
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.33Np Likeness Score: -0.50

References

1. Deng Y, Zhou X, Kugel Desmoulin S, Wu J, Cherian C, Hou Z, Matherly LH, Gangjee A..  (2009)  Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry.,  52  (9): [PMID:19371039] [10.1021/jm8011323]

Source